PubRank

H U Demuth

Author PubWeight™ 25.42‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The role of dipeptidyl peptidase IV in human T lymphocyte activation. Inhibitors and antibodies against dipeptidyl peptidase IV suppress lymphocyte proliferation and immunoglobulin synthesis in vitro. Eur J Immunol 1987 1.24
2 Improved glucose tolerance in Zucker fatty rats by oral administration of the dipeptidyl peptidase IV inhibitor isoleucine thiazolidide. Diabetes 1998 1.10
3 Dipeptidyl peptidase IV (DPIV/CD26) degradation of glucagon. Characterization of glucagon degradation products and DPIV-resistant analogs. J Biol Chem 2000 1.01
4 Dipeptidyl peptidase IV in human T lymphocytes. Impaired induction of interleukin 2 and gamma interferon due to specific inhibition of dipeptidyl peptidase IV. Scand J Immunol 1989 0.97
5 Improved glucose tolerance in rats treated with the dipeptidyl peptidase IV (CD26) inhibitor Ile-thiazolidide. Metabolism 1999 0.97
6 Characterization of dipeptidyl peptidase IV (CD26) from human lymphocytes. Clin Chim Acta 1992 0.94
7 Investigation of glucose-dependent insulinotropic polypeptide-(1-42) and glucagon-like peptide-1-(7-36) degradation in vitro by dipeptidyl peptidase IV using matrix-assisted laser desorption/ionization-time of flight mass spectrometry. A novel kinetic approach. J Biol Chem 1996 0.93
8 Effect of ageing and diabetes on glucose-dependent insulinotropic polypeptide and dipeptidyl peptidase IV responses to oral glucose. Diabet Med 2000 0.90
9 Dipeptidyl peptidase IV in the immune system. Effects of specific enzyme inhibitors on activity of dipeptidyl peptidase IV and proliferation of human lymphocytes. Biol Chem Hoppe Seyler 1991 0.89
10 Effect of aging and diabetes on the enteroinsular axis. J Gerontol A Biol Sci Med Sci 2001 0.89
11 Substrates containing phosphorylated residues adjacent to proline decrease the cleavage by proline-specific peptidases. Biochim Biophys Acta 1996 0.84
12 Dipeptidyl peptidase IV of human lymphocytes. Evidence for specific hydrolysis of glycylproline p-nitroanilide in T-lymphocytes. Biochem J 1984 0.84
13 N,O-diacylhydroxylamines as enzyme-activated inhibitors for serine proteases. Pharmazie 1983 0.83
14 N,O-diacyl hydroxamates as selective and irreversible inhibitors of cysteine proteinases. Methods Enzymol 1994 0.83
15 Enzymic properties of intestinal aminopeptidase P: a new continuous assay. FEBS Lett 1988 0.80
16 Potent and selective inactivation of cysteine proteinases with N-peptidyl-O-acyl hydroxylamines. Biochem J 1989 0.79
17 The dipeptidyl peptidase IV, a membrane enzyme involved in the proliferation of T lymphocytes. Biomed Biochim Acta 1985 0.79
18 Inactivation of subtilisin Carlsberg by N-((tert-butoxycarbonyl)alanylprolylphenylalanyl)-O-benzoylhydroxyl- amine: formation of a covalent enzyme-inhibitor linkage in the form of a carbamate derivative. Biochemistry 1994 0.79
19 Novel N-peptidyl-O-acyl hydroxamates: selective inhibitors of cysteine proteinases. Biochim Biophys Acta 1993 0.79
20 Effects of the CLIP fragment ACTH 20-24 on the duration of REM sleep episodes. Neuropeptides 1997 0.78
21 Role of glucose in chronic desensitization of isolated rat islets and mouse insulinoma (betaTC-3) cells to glucose-dependent insulinotropic polypeptide. J Endocrinol 2000 0.78
22 Peptidyl ammonium methyl ketones as substrate analog inhibitors of proline-specific peptidases. J Enzyme Inhib 1993 0.77
23 CD26 (dipeptidyl peptidase i.v.) on human T lymphocytes does not mediate adhesion of these cells to endothelial cells or fibroblasts. Immunobiology 1998 0.77
24 Relationship between primary structure and activity in exorphins and endogenous opioid peptides. FEBS Lett 1992 0.77
25 Enzymatic activity of CD26 (dipeptidylpeptidase IV) is not required for its signalling function in T cells. Immunobiology 1993 0.77
26 Cyclic morphiceptin analogs: cyclization studies and opioid activities in vitro. Int J Pept Protein Res 1996 0.76
27 Contamination of highly purified human serum cholinesterase by dipeptidyl peptidase IV causing hydrolysis of substance P. Pharmazie 1986 0.76
28 Analogs of glucose-dependent insulinotropic polypeptide with increased dipeptidyl peptidase IV resistance. Adv Exp Med Biol 2000 0.76
29 Intrathecal administration of p-hydroxymercuribenzoate or phosphoramidon/bestatin-combined induces antinociceptive effects through different opioid mechanisms. Neuropeptides 1998 0.75
30 Efficacy of the dipeptidyl peptidase IV inhibitor isoleucine thiazolidide (P32/98) in fatty Zucker rats with incipient and manifest impaired glucose tolerance. Diabetes Obes Metab 2007 0.75
31 Nature of the inactivation of elastase by N-peptidyl-O-aroyl hydroxylamine as a function of pH. Biochemistry 1995 0.75
32 Inhibition of dynorphin converting enzymes from human spinal cord by N-peptidyl-O-acyl hydroxylamines. J Biochem 1993 0.75
33 Kinetic analysis of enzymatic and nonenzymatic degradation of peptides by MALDI-TOFMS. Methods Mol Biol 2000 0.75
34 Inhibition of dipeptidyl peptidase IV (DP IV, CD26) activity abrogates stress-induced, cytokine-mediated murine abortions. Scand J Immunol 2001 0.75
35 Immunoprecipitation and liquid chromatographic-mass spectrometric determination of the peptide glucose-dependent insulinotropic polypeptides GIP1-42 and GIP3-42 from human plasma samples. New sensitive method to analyze physiological concentrations of peptide hormones. J Chromatogr A 2001 0.75
36 Reaction of dipeptidylpeptidase IV with substrate-analogous azapeptides. J Enzyme Inhib 1991 0.75